Univercells
OverviewSuggest Edit
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%.
Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based on single-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.
Univercells positions itself as a global partner for developing biomanufacturing/biosimilar solution, going from the process design, to the selection of the best technologies (USP, DSP, filing technologies, etc), to the design of the clinical plan, the process development, the technology transfer, the facility construction or the training of the staff.
| Type | Private | |
| Founded | 2013 | |
| HQ | Charleroi, BE | Map |
| Website | univercells.com |
Recent NewsAll News
Latest Updates
| Employees (est.) (Mar 2020) | 152 | (+6%) |
Key People/Management at Univercells
Hugues Bultot
Vincent Vanderborght
Cécile Jacoby
Christian Borgniet
David Louvet
David Shofi
Univercells Office Locations
Univercells Financials and Metrics
Summary Metrics
Founding Date | 2013 |
Univercells total Funding | $37.7 m |
Univercells latest funding size | $18.80 m |
Time since last funding | 2 years ago |
Univercells investors | Takeda Ventures, Bill & Melinda Gates Foundation, Global Health Investment Fund |
Univercells Online and Social Media Presence
304 Twitter followers
Univercells has 304 Twitter Followers. The number of followers has increased 3.5% month over month and increased 6.3% quarter over quarter
Univercells's Trends
Twitter Engagement Stats for @biologicsforall
439
Tweets
282
Following
304
Followers
22
Tweets last 30 days
1.9
Avg. likes per Tweet
90.9%
Tweets with engagement
Univercells News and Updates
Univercells nets $3.56 mln Series A
Univercells Blogs
Protected: Promising Vero cell growth in scale-X™ bioreactors
COVID-19 update: A word from our CEO to our partners & customers
Univercells launches CDMO Exothera with GMP capabilities in 15,000m² site in Jumet, Belgium
Univercells secures up to €50M investment from KKR platform to speed delivery of manufacturing technologies
Univercells boosted by EUR 20M European financing to accelerate the delivery of its vaccine portfolio
Univercells expands its development capacity with modular laboratories
Univercells Frequently Asked Questions
When was Univercells founded?
Univercells was founded in 2013.
Who are Univercells key executives?
Univercells's key executives are Hugues Bultot, Vincent Vanderborght and Cécile Jacoby.
How many employees does Univercells have?
Univercells has 152 employees.
Who are Univercells competitors?
Competitors of Univercells include Centrexion, Principia BioPharma and Rapid Micro Biosystems.
Where is Univercells headquarters?
Univercells headquarters is located at Rue Auguste Piccard 48, Charleroi.
Where are Univercells offices?
Univercells has offices in Charleroi, Nivelles and Woluwe-Saint-Pierre.
How many offices does Univercells have?
Univercells has 3 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies